SYNPO2 and breast cancer: EDG1 is a G protein-coupled receptor involved in cell-cell adhesion, reported as a novel antiproliferative protein, whose inhibition increases breast cancer cell growth [58]; SYNPO2, has been recently characterized as a tumour suppressor gene that inhibits cancer growth and metastasis both in vitro and in animal models [59].